Thus, differences in the cellular sources of MTAP and MTA could also account for enhanced MTA levels in NASH, although MTAP levels in total liver tissue were similar as in normal liver tissue. This evidence concerns the gene MTAP and metabolic dysfunction-associated steatohepatitis.